Literature DB >> 27454561

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Reshma Kassanjee1, Christopher D Pilcher, Michael P Busch, Gary Murphy, Shelley N Facente, Sheila M Keating, Elaine Mckinney, Kara Marson, Matthew A Price, Jeffrey N Martin, Susan J Little, Frederick M Hecht, Esper G Kallas, Alex Welte.   

Abstract

OBJECTIVE: Assays for classifying HIV infections as 'recent' or 'nonrecent' for incidence surveillance fail to simultaneously achieve large mean durations of 'recent' infection (MDRIs) and low 'false-recent' rates (FRRs), particularly in virally suppressed persons. The potential for optimizing recent infection testing algorithms (RITAs), by introducing viral load criteria and tuning thresholds used to dichotomize quantitative measures, is explored.
DESIGN: The Consortium for the Evaluation and Performance of HIV Incidence Assays characterized over 2000 possible RITAs constructed from seven assays (Limiting Antigen, BED, Less-sensitive Vitros, Vitros Avidity, BioRad Avidity, Architect Avidity, and Geenius) applied to 2500 diverse specimens.
METHODS: MDRIs were estimated using regression, and FRRs as observed 'recent' proportions, in various specimen sets. Context-specific FRRs were estimated for hypothetical scenarios. FRRs were made directly comparable by constructing RITAs with the same MDRI through the tuning of thresholds. RITA utility was summarized by the precision of incidence estimation.
RESULTS: All assays produce high FRRs among treated patients and elite controllers (10-80%). Viral load testing reduces FRRs, but diminishes MDRIs. Context-specific FRRs vary substantially by scenario - BioRad Avidity and Limiting Antigen provided the lowest FRRs and highest incidence precision in scenarios considered.
CONCLUSION: The introduction of a low viral load threshold provides crucial improvements in RITAs. However, it does not eliminate nonzero FRRs, and MDRIs must be consistently estimated. The tuning of thresholds is essential for comparing and optimizing the use of assays. The translation of directly measured FRRs into context-specific FRRs critically affects their magnitudes and our understanding of the utility of assays.

Entities:  

Mesh:

Year:  2016        PMID: 27454561      PMCID: PMC5024345          DOI: 10.1097/QAD.0000000000001209

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  26 in total

1.  Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Amy E Oliver; Caroline E Mullis; Kevin P Eaton; Amy C Mueller; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Charles R Rinaldo; Thomas C Quinn; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-01       Impact factor: 2.205

Review 2.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Authors:  Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

3.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Authors:  John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

4.  A new general biomarker-based incidence estimator.

Authors:  Reshma Kassanjee; Thomas A McWalter; Till Bärnighausen; Alex Welte
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

5.  Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.

Authors:  Silvina Masciotra; J Steven McDougal; Jane Feldman; Patrick Sprinkle; Laura Wesolowski; S Michele Owen
Journal:  J Clin Virol       Date:  2011-10-05       Impact factor: 3.168

6.  Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays.

Authors:  Barbara Suligoi; Anna Rodella; Mariangela Raimondo; Vincenza Regine; Luigina Terlenghi; Nino Manca; Salvatore Casari; Laura Camoni; Maria Cristina Salfa; Claudio Galli
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

7.  Estimation of HIV incidence using multiple biomarkers.

Authors:  Ron Brookmeyer; Jacob Konikoff; Oliver Laeyendecker; Susan H Eshleman
Journal:  Am J Epidemiol       Date:  2013-01-09       Impact factor: 4.897

8.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

9.  Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Authors:  Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Sheila M Keating; Shelley N Facente; Elaine McKinney; Matthew A Price; Jeffrey N Martin; Susan Little; Frederick M Hecht; Esper G Kallas; Alex Welte; Michael P Busch; Gary Murphy
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

View more
  40 in total

1.  Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.

Authors:  Eduard Grebe; Alex Welte; Jake Hall; Sheila M Keating; Shelley N Facente; Kara Marson; Jeffrey N Martin; Susan J Little; Matthew A Price; Esper G Kallas; Michael P Busch; Christopher D Pilcher; Gary Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

2.  Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.

Authors:  Briana A Lynch; Eshan U Patel; Colleen R Courtney; Aubin J Nanfack; Jude Bimela; Xiaohong Wang; Issa Eid; Thomas C Quinn; Oliver Laeyendecker; Phillipe N Nyambi; Ralf Duerr; Andrew D Redd
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

3.  Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.

Authors:  Ethan Klock; George Mwinnya; Leigh Anne Eller; Reinaldo E Fernandez; Hannah Kibuuka; Sorachai Nitayaphan; Josphat Kosgei; Richard D Moore; Merlin Robb; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2020-05-27       Impact factor: 2.205

Review 4.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

5.  Estimating HIV Incidence Using a Cross-Sectional Survey: Comparison of Three Approaches in a Hyperendemic Setting, Ndhiwa Subcounty, Kenya, 2012.

Authors:  Stéphanie Blaizot; Andrea A Kim; Clement Zeh; Benjamin Riche; David Maman; Kevin M De Cock; Jean-François Etard; René Ecochard
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-13       Impact factor: 2.205

6.  Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Authors:  Kelly E Seaton; Nathan A Vandergrift; Aaron W Deal; Wes Rountree; John Bainbridge; Eduard Grebe; David A Anderson; Sheetal Sawant; Xiaoying Shen; Nicole L Yates; Thomas N Denny; Hua-Xin Liao; Barton F Haynes; Merlin L Robb; Neil Parkin; Breno R Santos; Nigel Garrett; Matthew A Price; Denise Naniche; Ann C Duerr; Sheila Keating; Dylan Hampton; Shelley Facente; Kara Marson; Alex Welte; Christopher D Pilcher; Myron S Cohen; Georgia D Tomaras
Journal:  JCI Insight       Date:  2017-12-21

7.  Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

Authors:  Katherine E Schlusser; Shweta Sharma; Pola de la Torre; Giuseppe Tambussi; Rika Draenert; Angie N Pinto; Julia A Metcalf; Danielle German; James D Neaton; Oliver Laeyendecker
Journal:  AIDS Behav       Date:  2018-07

8.  HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.

Authors:  Marion Vermeulen; Dhuly Chowdhury; Ronel Swanevelder; Eduard Grebe; Donald Brambilla; Ute Jentsch; Michael Busch; Gert Van Zyl; Edward L Murphy
Journal:  Vox Sang       Date:  2020-08-06       Impact factor: 2.144

9.  Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance Surveillance.

Authors:  Sung Yong Park; Gina Faraci; Gary Murphy; Christopher Pilcher; Michael P Busch; Ha Youn Lee
Journal:  J Infect Dis       Date:  2021-09-17       Impact factor: 5.226

10.  Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.

Authors:  Kelly A Curtis; Donna L Rudolph; Yi Pan; Kevin Delaney; Kathryn Anastos; Jack DeHovitz; Seble G Kassaye; Carl V Hanson; Audrey L French; Elizabeth Golub; Adaora A Adimora; Igho Ofotokun; Hector Bolivar; Mirjam-Colette Kempf; Philip J Peters; William M Switzer
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.